Amlodipine and frusemide: pharmacological factors contributing to increased fall risk in concurrently treated patients - a retrospective cross-sectional study
- PMID: 40792214
- PMCID: PMC12336181
- DOI: 10.3389/fphar.2025.1598161
Amlodipine and frusemide: pharmacological factors contributing to increased fall risk in concurrently treated patients - a retrospective cross-sectional study
Abstract
Background: Calcium channel blockers, such as amlodipine, are commonly prescribed for hypertension but can cause peripheral edema, often requiring adjunctive frusemide. Concerns exist regarding the potential increase in fall risk, particularly in older populations. However, few studies have assessed the prevalence of amlodipine and frusemide combination (AFC) prescriptions and their association with fall risk factors.
Objectives: The aims of this study are to determine the prevalence of AFC prescriptions and evaluate their association with fall risk factors in an outpatient cardiology clinic population.
Methods: This retrospective, cross-sectional study included patients aged ≥40 years from Al-Qatif Central Hospital's outpatient cardiology clinic (January 2021 -December 2022) prescribed amlodipine. Fall risk factors were identified from literature. The Charlson Comorbidity Index (CCI) was used to estimate 1-year mortality risk. The number of prescribed orthostatic hypotension-inducing drugs (OHDs) and fall-risk increasing drugs (FRIDs) was recorded. Binary logistic regression was performed to determine the association between AFC prescriptions and fall risk factors, adjusting for significant covariates. Results are expressed as adjusted odds ratios (OR) with 95% confidence intervals (CI).
Results: Of 3,681 patients, 18%. Were prescribed AFC. AFC patients were older (70 vs. 64 years, P < 0.001), had a higher prevalence of diabetes mellitus (64% vs. 44%, P < 0.001), anemia (55% vs. 32%, P < 0.001), and osteoporosis (51% vs. 28%, P < 0.001), and received more OHDs prescriptions (2.8 vs. 1.3, P < 0.001) compared to non-AFC patients. Higher CCI scores (OR = 1.51, 95% CI 1.41-1.62) and more OHDs prescriptions (OR = 2.5, 95% CI 2.3-2.7) were significantly associated with AFC prescriptions.
Conclusion: AFC prescriptions are prevalent, and patients prescribed AFC have higher prevalence of fall risk factors. Comprehensive patients assessment is essential to minimize fall risk and related complications.
Keywords: amlodipine; fall risk; frusemide; orthostatic hypotension; prescribing cascade.
Copyright © 2025 Alqurain, Albaharnah, Al Zayer, Alanzi, Alblushi, Aleid, Ashoor, Albahrani, Almahdi, Al-Shaibi, Ameer, Ghosn, Algoraini, Alsubaie, Alshnbari and Alomar.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures
Similar articles
-
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.Health Technol Assess. 2001;5(32):1-195. doi: 10.3310/hta5320. Health Technol Assess. 2001. PMID: 12065068
-
Sexual Harassment and Prevention Training.2024 Mar 29. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. 2024 Mar 29. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. PMID: 36508513 Free Books & Documents.
-
Falls prevention interventions for community-dwelling older adults: systematic review and meta-analysis of benefits, harms, and patient values and preferences.Syst Rev. 2024 Nov 26;13(1):289. doi: 10.1186/s13643-024-02681-3. Syst Rev. 2024. PMID: 39593159 Free PMC article.
-
Prescription trends of gastric acid suppressants and association with potential adverse events in Korea: a real-world cross-sectional study.Therap Adv Gastroenterol. 2025 Jul 15;18:17562848251356406. doi: 10.1177/17562848251356406. eCollection 2025. Therap Adv Gastroenterol. 2025. PMID: 40672976 Free PMC article.
-
Inhaled steroids and risk of pneumonia for chronic obstructive pulmonary disease.Cochrane Database Syst Rev. 2014 Mar 10;2014(3):CD010115. doi: 10.1002/14651858.CD010115.pub2. Cochrane Database Syst Rev. 2014. PMID: 24615270 Free PMC article.
References
-
- Alqurain A., Alomar F. A., Albaharnah M. H., Alzayer S. H., Ameer L., Ghosn S. A., et al. (2024a). The prevalence of polypharmacy and hyper-polypharmacy among middle-aged vs older patients in Saudi Arabia: a cross-sectional study. Front. Pharmacol. 15, 1357171. 10.3389/fphar.2024.1357171 - DOI - PMC - PubMed
-
- Alqurain A. A., Alomar M. F., Fakhreddin S., Julayh Z., Korikeesh Z., Al-Shaibi S., et al. (2024b). Pattern of prescribing proton pump inhibitors: evaluating appropriateness and factors contributing to their adverse effect reaction risk. J. Clin. Med. 13, 6187. 10.3390/jcm13206187 - DOI - PMC - PubMed
LinkOut - more resources
Full Text Sources